Sign in

Prof Nancy Devlin

@prof-nancy-devlin.bsky.social
1.1K followers 611 following 109 posts

Editor in Chief at Value in Health, Board chair at EuroQol Research Foundation, Rotterdam & Professor of Health Economics at University of Melbourne. Proud mum of three wonderful adults and grandma to two very energetic tiny humans.

PostsRepliesMedia
Reposted by Prof Nancy Devlin
EuroQol Research Foundation @euroqol.bsky.social · 12/11/2025
🌍 EQ-5D-5L value sets are now available for 40+ countries - a global effort to make health measurement comparable & meaningful across populations. @prof-nancy-devlin.bsky.social et al explore the developments and what's next for the EQ-5D in their paper. Read here 👉 bit.ly/4m9UGro
Graphic promoting publication "Measuring and valuing health using EuroQol instruments: new developments 2025". The graphic features a world map highlighting countries where EQ-5D-5L value sets are available, indicated in dark blue.
141
Reposted by Prof Nancy Devlin
EuroQol Research Foundation @euroqol.bsky.social · 19/08/2025
EQ-TIPS was developed to meet growing interest in evaluating the effectiveness & cost-effectiveness of treatments in very young children 👶 In this paper, @prof-nancy-devlin.bsky.social et al. examine issues in valuing the EQ-TIPS and possible adaptations to valuation methods 👉 bit.ly/4oxl4gF
Text: ‘Publication, Paper Tuesday - Valuing health states for infants and toddlers: challenges and methodological considerations in EQ-TIPS preferences elicitation. by Devlin, N. et al. (2025).' The background is a gradient blue with overlaid images of books and the world map.
052
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 28/07/2025
in a good way, though, I hope! :-)
110
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 27/07/2025
New paper: "Measuring & Valuing Health Using EuroQol Instruments: New Developments 2025 and Beyond" ▶️open access: tinyurl.com/EuroQol2025u... @fengtastic.bsky.social @beaunebeaune.bsky.social @ellystolk.bsky.social #HealthEconomics #PROMS #HRQOL #EQ-5D #EQ-5D-Y #EQ-HWB-9 #EQ-TIPS #Bolt-ons
Highlight points from a new paper summarising established and new tools for measuring and valuing health related quality of life, developed by a not for profit organisation called the EuroQol Research Foundation.
060
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 23/07/2025
Thanks @frasermorton.bsky.social for adding the Australian value set for the EQ-5D-Y-3L to your #rstats #EQ5D package! That was quick work! @euroqol.bsky.social @rich-norman.bsky.social Our paper is available here, open access: ➡️https://tinyurl.com/AussieY-3Lvalueset
tinyurl.com
An Australian Value Set for the EQ-5D-Y-3L - Health and Quality of Life Outcomes
Background Australia has a well-established health technology assessment process and there is extensive use of generic health related quality of life (HRQoL) instruments in evidence presented to it. H...
050
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 12/07/2025
I'm looking forward to the 2025 #iHEA Congress, & the pre-congress @euroqol.bsky.social session. Authors: If you're presenting a paper at iHEA & thinking of submitting it to #ValueinHealth - drop me a message! I'll do my best to come to your session. Or just come up & say hi! #healtheconomics #VIH
041
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 11/07/2025
Will Trump's plan to use 'Reference Pricing' cut US drug prices? This #ValueinHealth paper by Grueger, Martin & Sullivan argues reference pricing is ill-advised & will lead to unintended consequences. open access 👉 tinyurl.com/reference-pr... #Trump #HealthEconomics
Image is copyright to Jane Doe/ Shutterstock. Shows a cartoon image of Donald Trump with a signed Executive Order
142
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 22/06/2025
News from the English NHS: www.bbc.com/news/article... #genomics #precisionmedicine @eigen-uom.bsky.social
bbc.com
NHS plans to DNA test all babies in England to assess disease risk
Scheme is part of the government's 10-year plan for the NHS in England aimed at easing pressure on services.
010
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 22/06/2025
New impact factor for Value in Health. We're chuffed! #healtheconomics
just a big yellow-coloured number 6.0
1120
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 22/06/2025
This letter, in the June issue of Value in Health, makes for pretty interesting reading: www.valueinhealthjournal.com/article/S109... #healtheconomics #equity #HTA
valueinhealthjournal.com
Why Is Distributional Cost-Effectiveness Analysis Not Ready for Prime Time in Health Technology Assessment?
The systematic review by Merga et al1 examining economic evaluations that address inequalities in cancer care had a striking result in that only 13% of studies identified used distributional cost-effe...
010
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 22/06/2025
New Value in Health paper, "Drop the M", of interest to anyone struggling with how to interpret data from patient reported outcome measures, and what a Minimally Important Difference means. Authors: Vickers, Nolla & Cella. 👉 pubmed.ncbi.nlm.nih.gov/40216310/ #HealthEconomics
pubmed.ncbi.nlm.nih.gov
Drop the "M": Minimally Important Difference and Change Are Not Independent Properties of an Instrument and Cannot Be Determined as a Single Value Using Statistical Methods - PubMed
MID must be estimated within a specific study context. It is best to think of PRO measures in terms of "ID" and leave the "M" to case-by-case, context-based interpretation.
010
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 18/06/2025
Thank you!! 👍
020
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 15/06/2025
Hey @altmetric.com, I was wondering if you've got any updates on this you could share? #AcadmicSky #EconSky
1162
Reposted by Prof Nancy Devlin
David Edmonds @davidedmonds100.bsky.social · 06/05/2025
Two great philosophers retiring. Two conferences to honour them. Two great line ups. Both open to the public. Sign up. Jo Wolff www.bsg.ox.ac.uk/events/publi... & Jeff McMahan www.ccc.ox.ac.uk/alumni/event...
bsg.ox.ac.uk
The Public Philosopher
Join us for a day of philosophical discussion in honour of Professor Jo Wolff's career.
062
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 17/05/2025
Nice work @lauratrigg.bsky.social! 🙌 We need to see much more of this kind of evidence on the cost effectiveness of existing healthcare interventions. b.t.w,@jappleby123.bsky.social @koonalshah.bsky.social looked at hip surgery in 2013, using NHS PROMS data: pubmed.ncbi.nlm.nih.gov/23759892/
pubmed.ncbi.nlm.nih.gov
Using patient-reported outcome measures to estimate cost-effectiveness of hip replacements in English hospitals - PubMed
Using the new patient-assessed health-related quality of life data combined with routine hospital-level cost data it is possible to estimate a procedure-based measure of efficiency for hospitals. The ...
111
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 16/05/2025
Tomorrow at #ISPOR2025: in this 75-min 'spotlight' session we will give in-depth consideration of whether Cost Benefit Analysis could play a bigger role in HTA. If you are here in Montreal, I hope to see you there! #HealthEconomics
A powerpoint slide from Prof. Devlin linking the case for CBA to the need for cross-sectoral economic evaluation
040
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 16/05/2025
An update on NICE methods regarding health inequalities in health technology evaluations is out now: tinyurl.com/NICEmethodsh... #HealthEconomics
nice.org.uk
Health inequalities - an update to NICE’s methods for health technology evaluation
030
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 14/05/2025
@euroqol.bsky.social puts out these useful posts regularly, where they do a quick ‘round-up ’ of new papers published about EQ-5D and related instruments. I find therir posts very helpful. If you’re interested in HRQoL, utilities etc, it’s worth following them! #HealthEconomics #PROMs
031
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 14/05/2025
#ISPORAnnual Virginia Acha notes that tough pricing regulation in the US will reduce incentives for investment in innovation - and this is a double whammy if coupled with reduced US funding of basic science. #referencepricing #HealthEconomics
060
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 14/05/2025
At ISPOR 2025 Darius Lakdawalla: some form of price intervention is now inevitable in the US, hopefully based on value, and done in a ‘US specific way’. Time for the US to adopt its own HTA.
011
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 14/05/2025
At today’s ISPOR conference: Sean Sullivan arguing US reference pricing is ‘lazy and misguided’ - but has bipartisan support.
000
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 13/05/2025
I'm guessing this is going to be a hot topic of conversation here at ISPOR Montreal over the coming days! www.theguardian.com/business/202... #HealthEconomics
theguardian.com
Drug price cuts: what is Trump planning and what will it mean for big pharma?
President has directed Robert Kennedy to send price targets to industry, with slimming drugs thought to be included
020
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 12/05/2025
Will the US introduce 'reference pricing'? www.reuters.com/business/hea...
reuters.com
Trump to sign executive order on reducing prescription drug prices
U.S. President Donald Trump said on Sunday he would sign an executive order that he said would reduce prescription drug and pharmaceutical prices by between 30% and 80%.
010
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 12/05/2025
[2/2] So, after the 10-year exclusivity period ends, what happens? Not much: despite expectations of price reductions, the authors observe that many orphan meds seem to lack competition. @amsterdamumc.bsky.social This 'Editor's Choice' paper is available open access: tinyurl.com/EUOrphanMeds
030
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 12/05/2025
[1/2] "24 yrs After the Launch of the EU Orphan Regulation: Analyzing Dutch Price Dynamics, Biosimilars & Generics for Orphan Medicinal Products"by Sibren van den Berg & colleagues in the May issue of Value in Health @amsterdamumc.bsky.social 👉 tinyurl.com/EUOrphanMeds #HealthEconomics
abstract of a new paper just published in Value in Health, May 2025, Twenty-Four Years After the Launch of the EU Orphan Regulation: Analyzing Dutch Price Dynamics, Biosimilars, and Generics for Orphan Medicinal Products
120
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 12/05/2025
"The Price Effects of Biosimilars In the US" by Mireia Jofre-Bonet et al. concludes the US biosimilars market has become highly competitive; driving price reductions between 2015-2023 with substantial savings for Medicare ➡️ tinyurl.com/PriceEffects... @ohenews.bsky.social #HealthEconomics
abstract of a new paper in Value in Health, May 2025,  by Mireia Jofre-Bonet and colleagues about the effect of biosimilars on prices in the US
021
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 08/05/2025
Are women under-represented in publishing in #HealthEconomics? We did an analysis of submissions and acceptances to Value in Health. Results are quite encouraging - but still scope for improvement. open access paper here: tinyurl.com/WomenAuthors...
highlight points from a paper published in Value in Health, looking at how well women are represented in authorship of papers submitted and accepted by the journal.
082
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 07/05/2025
What is 'Whole Health' and what does it mean for approaches to economic evaluation? The new issue of Value in Health has articles on this from US CDC, WHO & ISPOR, and this little editorial from me & fellow editors Daniel Mullins & Pieter van Baal: 👉 tinyurl.com/WhatDoesWhol... #HealthEconomics
screenshot of an editorial in the May 2025 issue of Value in Health. The paper discussed what the term 'Whole Health' means and discuses some of the implications for how we evaluate costs and benefits.
050
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 29/04/2025
I love it when someone really interesting is interviewed on the news sitting in front of their bookcase. @maryrziegler.bsky.social's new book, 'Personhood: The New Civil War Over Reproduction' now added to my reading list. @cnn.com
Photo of author and researcher Mary Ziegler being interviewed on CNN about her new book, 'Personhood: the new civil war over reproduction'.
010
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 27/04/2025
When QALYs, VAS and standard gamble make it onto TV... tinyurl.com/38xvf8vy
linkedin.com
#universitychallenge | Chloë Hardern | 16 comments
Health economics spotted in the wild… did anyone else get 100%? 💅 #universitychallenge | 16 comments on LinkedIn
020
Reposted by Prof Nancy Devlin
Benjamin Balthaser @blbalthaser.bsky.social · 25/04/2025
Indiana state legislature just staged a hostile takeover of IU, functionally eliminating tenure, promising to close smaller (hum) majors, taking over the IU board, and cutting the IU budget. This is so bleak
631355688
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 26/04/2025
Since it’s the weekend- what are you all reading? Here are my favourite books from the last six months. ‘Atlas of AI’, ‘Character Limit’ & ‘Careless People’ all strongly recommended to understand the tech world. And some excellent fiction for temporary respite from it! #booksky @rcshuker.bsky.social
A picture taken by Nancy Devlin of the books she has most enjoyed reading in the last 6 months. Careless People; Nothing to see here; The Royal Free; Butter, All Fours; and Character Limit.
182
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 25/04/2025
How are X and @bsky.app performing as platforms for disseminating research? Fascinating @altmetric.com analysis here: www.altmetric.com/blog/bluesky... #AcademicSky #EconSky
altmetric.com
Bluesky’s ahead, but is X a dead parrot?
Altmetric has been capturing and integrating Bluesky posts since October 2024. What does the data look like now?
0142
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 25/04/2025
Hey everyone! Well known British professor of health economics @paul-kind.bsky.social has joined @bsky.app. Paul always has interesting/thought provoking things to say- give him a follow! #healtheconomics
020
Reposted by Prof Nancy Devlin
John Mullahy @johnmullahy.bsky.social · 22/04/2025
Joe's remarkable scholarship and dedication have shaped the field of health economics in broad, deep, and enduring ways. Congratulations. www.aeaweb.org/about-aea/ho...
1151
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 22/04/2025
Having lived in the UK for several decades, I am still not adjusted to the topsy-turvy seasons back in NZ. It's Autumn and it's cold - but it's Easter holidays - so we hid the kids' easter eggs in the piles of fallen leaves & thinking about carving a pumpkin...with... a rabbit face?!
Picture of an Easter egg hidden in a pile of autumn leaves in New Zealand. Whereas Easter coincides with spring in the northern hemisphere, in the southern hemisphere it occurs in Autumn, when there are falling leaves and pumpkins and bonfires.
040
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 20/04/2025
"Using Outcome Information During Consultation Yields Better Shared Decision Making, Better Patient Experiences, and More Positive Expectations" - paper on the use of PROs data in clinical settings, in April 2025 issue of Value in Health by Loos et al. ➡️ tinyurl.com/9fb6m4k7 #HealthEconomics #PROMs
Figure from a paper published in Value in Health. The Figure shows how patient reported outcomes data was used In clinical consultations, via a Dashboard.
000
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 20/04/2025
Also at ISPOR Montreal 2025: I'll be moderating this in-depth session on the use of CBA in #HealthEconomics Friday 16th May 10-11.15am
programme entry for the ISPOR May 2025 conference in Montreal, describing a session which will debate the use of cost benefit analysis in health technology assessment.
030
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 20/04/2025
2/2 Links to the papers here: 👉 pubmed.ncbi.nlm.nih.gov/35941004/ 👉 pubmed.ncbi.nlm.nih.gov/35279370/ ❓Got any Questions you'd like us to ask the authors about these topics❓
000
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 20/04/2025
1/2 Going to ISPOR Montreal 2025? May 15th 11.30am: Value in Health's editors-in-chief are having a 'fireside chat' with the lead authors of the 'Paper of the Year' in 2024 (Aurelie Meunier) & 2023 @peterneumann.bsky.social
screen shot of the programme for ISPOR Montreal, May 2025, showing the session details for Value in Health Editors in Child having a fireside chat with the lead authors of the Papers of the Year in 2024 and 2023.
120
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 19/04/2025
I worry that some topics addressed in health econ journals could draw fire just because (stupidly) they 'sound a bit like DEI' e.g. DCEA methods, health inequality aversion; analysis of policies to improve access. Editors of academic journals need to be ready to defend independence #HealthEconomics
110
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 17/04/2025
Congratulations @martingaynor.bsky.social! #HealthEconomics
110
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 16/04/2025
The first time I saw this, I thought it was a joke. But nope - Reading to Dogs is an actual thing that happens every Monday night at my lovely little local library here in Wānaka, New Zealand. #libraries #literacy#Libsky
An advertisement for the Reading to Dogs programme at Wanaka Library. I'm sure the dogs like it, but the main point is to help children improve their literacy in a non-judgemental environment. That's probably why it's not Reading to Cats. Cats judge.
020
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 12/04/2025
What role does equity play in health technology assessment in Asia? New paper in Value in Health reviews current practice in 13 countries. Conclusion: Equity is considered in HTA, but use of quant methods (like DCEA) still relatively rare. tinyurl.com/HealthEquity... #HTA #HeathEconomics #equity
screen shot of the title page of an article in the April issue of Value in Health. The paper is called 'Role of health equity in HTA: a landscape analysis of 13 health systems in Asia'.
040
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 12/04/2025
2/2 The study identifies challenges with using the cTTO to elicit values < 0. Authors Meixia Liao, Zhihao Yang, Kim Rand, Mila Karimi & Nan Luo suggest improvements are needed. #HRQoL #TTO #preferences #EQ-5D #HealthEconomics @euroqol.bsky.social
The abstract and highlight points for a paper published in Value in Health, called "How do individuals value worse than dead EQ-5D-5L health rates in composite TTO Tasks? A qualitative study".
010
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 12/04/2025
1/2 In the April issue of Value in Health: this fascinating paper, using qualitative analysis to investigate 'How Individuals Value Worse-Than-Dead EQ-5D-5L Health States' using the composite TTO which is a standard part of @euroqol.bsky.social 'EQ-VT' valuation protocols. #HealthEconomics
screen shot of a task, called composite TTO, used to elicit values for health states that are considered either 'better than dead' or 'worse than being dead'
130
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 12/04/2025
Out now: the April 2025 issue of Value in Health features 8 papers on the economics of Alzheimers & related dementias; plus papers on a wide range of other topics in health economics & outcomes research. 👉 www.valueinhealthjournal.com/current #Alzheimers #HealthEconomics #ValueinHealth
screenshot of the cover of the peer reviewed journal called 'Value in Health'.
010
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 10/04/2025
Great to see you on @bsky.app , @patrickabraham.bsky.social and @devinefy.bsky.social , and congrats on your paper! #healtheconomics
020
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 06/04/2025
Love it! Tagging @thruthal.bsky.social who is in the unique position of being able to play this on his guitar, sing the lyrics, and provide a sophisticated account of the theory!
010
Prof Nancy Devlin @prof-nancy-devlin.bsky.social · 06/04/2025
This looks like a really interesting initiative that could yield useful advancements in methods, evidence & decision making. Well done @nihr.bsky.social @arc-west.bsky.social (& congrats @csrejon.bsky.social!) #HealthEconomics #ImplementationScience
121